Avibactam/ceftazidimeAcquired resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1972卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45454-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：73 / 73

相关论文

共 50 条

[21] CeftazidimeAcquired factor V inhibitor: case report
Reactions Weekly, 2015, 1555 (1) : 51 - 51
[22] Avibactam/ceftazidimeDevelopment of Klebsiella pneumoniae resistance: case report.
Reactions Weekly, 2021, 1846 (1) : 50 - 50
[23] Avibactam/ceftazidime/Polymixin-BDrug resistance : case report
Reactions Weekly, 2025, 2050 (1) : 90 - 90
[24] Amikacin/Avibactam/ceftazidimeLack of efficacy and acquired drug resistance: case report
Reactions Weekly, 2024, 2027 (1) : 29 - 29
[25] Avibactam/ceftazidimeThrombocytopenia : case report
Reactions Weekly, 2022, 1901 (1) : 107 - 107
[26] Avibactam/ceftazidimeGlycosuria: case report
Reactions Weekly, 2021, 1879 (1) : 59 - 59
[27] Avibactam/ceftazidimeThrombocytopenia: case report
Reactions Weekly, 2023, 1957 (1) : 74 - 74
[28] Avibactam/ceftazidimeNephrotoxicity: case report
Reactions Weekly, 2025, 2049 (1) : 61 - 61
[29] Avibactam/ceftazidimeNeurotoxicity: case report
Reactions Weekly, 2025, 2043 (1) : 65 - 65
[30] Avibactam/ceftazidimeHypokalaemia: case report
Reactions Weekly, 2024, 2027 (1) : 85 - 85

← 1 2 3 4 5 →